Full Transcript Introduction to Sylvie Beljanski 0:00 I have the absolute pleasure of of having Sylvie Beljanski with me today. 0:05 Sylvie Beljanski 0:06 and author, scientific communicator, advocate for integrative oncology. 0:11 She is president of the Beljanski Foundation and Mason, Beljanski 0:16 host of the Beljanski Cancer Talk Show 0:19 and founder of the Beljanski Integrative Cancer Conference. 0:23 She's a former French attorney. 0:25 She has spent more than three decades 0:28 advancing research inspired by the work of her father. 0:31 And that's an amazing, fascinating story that we're going to get into as well. 0:36 Her father, some molecular biologist, Doctor Mirko Beljanski 0:40 and she wrote an award winning book. 0:43 In 2018, Winning the War on Cancer, became an Amazon bestseller 0:48 and received numerous national and international honors. 0:52 And today, her work focuses on cancer, stem cell research, 0:56 education, prevention, responsible science 0:59 based and wellness, and public outreach. 1:02 And Sylvie, your your driving your you're doing 1:07 what other natural products I feel should do you know to really and I mean 1:13 your conferences and your foundations to raise money to be able to do 1:18 research on to really prove the substance and what it does. 1:23 And you've done that. 1:24 And I'm excited to talk about that research. 1:26 But, you know, we're going to cover so much today. 1:29 So thank you for being here. 1:31 Thank you for having me. 1:33 So so talk to me a little about your father. 1:35 He was the one that obviously I mean, he was a French scientist 1:39 and Pasteur University and institute and I mean, he 1:44 it was not that he was just a kind of somebody doing a little bit on the side. 1:49 He was kind of in the nitty gritty of.
Her Father's Scientific Legacy 1:51 Yeah, he was a PhD in molecular biology. 1:55 And so he got his PhD. 1:57 He was approached by the Pasteur Institute, 2:01 and he worked for decades at the Pasteur Institute. 2:04 And we got his PhD in 51 to give you an idea of the timeline. 2:10 And at the time. 2:12 So it was a time or so exciting time in biology 2:15 where the the genome was just discovered by Watson and Crick 2:19 and everybody at the time, so that cancer was a genetic disease. 2:24 And then some new understanding of the genome would explain everything. 2:29 And the future of medicine could only be genetic. 2:33 And my father was one of the first scientists to say, well, 2:36 if it was just in ethic, there would be a very definitive number of, of cancer. 2:43 It would there would not be any increase. 2:45 And in the 60s, I mean, there was already a lot of pollution after World War two, 2:50 a lot of pesticides that were, you know, started to be used if they were. 2:55 And there was an increased number in the number of cancer. 3:01 And my father said, well, just cannot be genetic. 3:04 There must be something else or something. 3:07 Three at least some gene. 3:09 And he was one of the first one to look at the environment 3:13 as a cause, but also as a solution to to cancer. 3:17 And he looked for natural compounds 3:21 that would be able to specifically make 3:25 the difference between cancer cells and healthy cells. 3:29 And he made the observation that when you have a cancer 3:33 cells, you always have, whether you look at humans, plants, 3:38 animals, you always have some big opening 3:41 between the two strands of the DNA. 3:44 But and healthy cells, you have the nice 3:48 double Alex well interwoven. 3:51 But when there is cancer is always big, big openings 3:55 that are linked to an increased rate of duplication of the DNA. 4:00 And it was able to find some botanicals 4:05 that are able to recognize those big loops between the strands of the DNA, 4:11 intercalated between those loops, and block 4:15 selectively the duplication of those concerns cells. 4:20 So we have one from head to toe. 4:24 So I mean, this kind of mechanical approach just, you know, ignore 4:29 or whether you have a breast cancer of iron cancer, 4:33 pancreatic cancer and lung cancer, it doesn't really matter. 4:37 You have now some plant extracts able to target cancer cells. 4:42 And and they don't go anywhere else. 4:45 So if they don't go anywhere else 4:47 also you have no toxicity no side effect to healthy cells. 4:52 So he published those results. 4:55 My father started to publish really intensively in the 70s and 80s, got 5:01 the interest of a lot of French doctors 5:04 who love the idea of a natural approach, 5:08 effective on all kinds of cancer and not toxicity, unhealthy cells. 5:14 So it created kind of movement 5:17 of doctors who were all willing to integrate 5:22 this natural approach to their conventional therapies. 5:26 And that was kind of movement, integrative therapies 5:31 that, of course, I mean, in the country as government heavy, 5:38 I would say, as Europe can be, was not well received. 5:43 And then in the early 90s, the French president, Francois 5:48 Mitterrand, was diagnosed with advanced prostate cancer. 5:53 And when he was sold. 5:55 Well, sir, I mean, you can spread everywhere 5:59 and there is not much that we can do besides giving you some thing. 6:04 I said, well, I have nothing to lose. 6:06 I want to try something else. 6:09 And he's he had a friend, lady friend 6:12 who knew about one of those integrative doctors 6:16 who were using with great success my father's products. 6:20 And that's how Mitterrand started to take the products and against all us, 6:26 the and for everybody to see, because there was no social media at the time. 6:30 But there was there was a state TV and the president was doing 6:35 better and better, and he was able to finish his second term. 6:39 Terms were seven years at the time. 6:41 And that created kind of havoc as a mean French Ministry of Health.
Government Crackdown and Foundation Origins 6:47 And the situation unprecedented. 6:50 And the church could not tolerate a few months after finally passed away, 6:56 the center, the army, the French army 6:59 to destroy my father's laboratory, to read everything. 7:03 They destroy the present like salvage. 7:06 Really like barbarians destroying knowledge. 7:10 And and that shocked me a lot to see, because I grew up 7:15 seeing so many people being held by my parents. 7:18 I did not want to get involved because it was just too much to 7:23 emotionally heavy to all this ongoing stream of people that were coming 7:29 all the time at the apartment begging for some kind of treatment. 7:33 And I said, it's not for me. 7:34 I'm going to law school. 7:36 But seeing this knowledge bank destroyed by 7:43 the army, 7:44 military men coming with machine guns 7:48 to destroy knowledge that can help people. 7:51 And this science is research has been paid 7:55 for decades by the French taxpayer. 7:59 My father was a Pasteur Institute. 8:01 This is paid. 8:02 I mean, it was paid by the French government. 8:04 And when the results of this research doesn't please 8:08 the government's government destroys the research. 8:11 And so that's why I started to take 8:14 legal defense of my father. 8:17 The more I was looking at the files, a more fishy it looked, the more obviously 8:22 it was not about what any wrongdoing that my father had done. 8:26 It was about destroying the evidence once and for all. 8:32 So after my father finally passed away, 8:35 I decided to start the foundation. 8:39 I did not want a knowledge to disappear. 8:42 I wanted first to confirm my father's work 8:46 because in France we are saying it has never been reproduced. 8:50 It's just spoken and no value. 8:54 Let's destroy it because it has no value. 8:56 Basically. That was right. 8:58 And I said, I'm going to first I want continuation. 9:02 And then I started to be able 9:05 to worked with invited the number of French doctors 9:09 who in New York to explain to them I was committed to continue, but 9:14 I needed their help because I did not know much about those products. 9:19 I did not know much about how to use them. 9:21 I did not know much about the science behind that. 9:24 I'm a lawyer, and I was able to invite 9:27 also a handful of American doctors. 9:30 Speaking of 99, 9:33 one of them was Doctor Michael Schachter, 9:36 who was a really wonderful man, wonderful doctor. 9:41 And it was it was really 9:44 carried away. 9:45 But what he heard from his French colleagues. 9:49 And at the end of the conference, he told me, well, I have a poor fellow 9:53 who has concrete cancer, so the poor guy 9:57 probably has not much to lose and probably little time. 10:00 But I would be happy to try one of your products, your 10:04 at least your product, to see if we can do something 10:09 and then a few weeks later equals means the poor fellow is doing better. 10:14 I'm going to try another cases 10:17 and after one year he told me, well, I have now enough good cases. 10:21 I'm going to publish about those results. 10:24 And that was the first American paper. 10:26 It was in a little, little magazine called film 10:31 as a lot of people were reading. 10:34 But I was so happy, so happy with that first American paper, 10:38 give a copy to everybody I knew, including my bunker. 10:42 And my bunker was a patient 10:46 of Doctor Aaron Katz at Columbia University. 10:49 And then Doctor Katz calls me 10:55 a call from Columbia University. 10:57 Little me, I was like, what's going on? 11:00 But he told me, you know, the thing seems interesting and was, 11:04 I mean, curious with the as a urologist, 11:08 the doctor Katz was really 11:11 interested with the story of the prostate of the French president. 11:15 And he told me, well, you know, if maybe if you give us some, 11:19 some plot of those plot who could do a study 11:23 on prostate cancer and to see how 11:26 they are reacting and confirm if yes or no, 11:30 those compounds are able to destroy prostate cancer cells. 11:34 And if we are going to start in vitro 11:37 and if it works, we will move to in vivo with mice.
Early U.S. Research and Prostate Cancer Studies 11:42 That was like going from president to the petri dish. 11:46 Is that science. 11:48 And but I felt, you know, that was the only way to go if I wanted 11:51 to develop some body of research in the here in the US. 11:57 And that's how we started with the Beljanski Foundation. 12:00 And so that grew from there. 12:02 We were able to work on prostate 12:06 cancer at with Columbia University. 12:09 Doctor Katz had several team at several publications 12:14 confirming that those extracts, power and revolver 12:19 were able to destroy cancer cells 12:22 that prostate cancer cells that moved also to inflammation. 12:27 Benign prostatic hyperplasia with a mechanism of action 12:32 on an F capability five alpha reductase, 12:36 all that body. 12:39 Then Doctor Katz was very pleased with the results, 12:43 and he started to speak himself about those new publications. 12:47 Then one day I was he was giving a conference. 12:50 I was sitting next to a lady who looks at me 12:53 and said, he's speaking about your your your extracts. 12:57 Right you are, Sylvie. 12:58 I said, yes, yes, yes, she introduced herself. 13:01 She is Doctor Driscoll from Kansas University Medical Center. 13:05 And she said, you know, it would be great if we could do some, 13:09 some similar research on ovarian cancer. 13:13 Do you have something for women? 13:15 And I said, yes, the same thing because it's not organ or gender specific. 13:21 It is little plant extracts or intercalated 13:24 between the two strands of the DNA when 13:27 and wherever they are destabilized. 13:31 And she said, okay, let's try on a variant cancer. 13:34 That's how we got this body of also publication 13:39 on ovarian cancer at Kansas University. 13:43 We did also in vitro and individual and mice. 13:47 We looked 13:48 at how they were confirmed that they were working by themselves, 13:52 inducing apoptosis of cancer cells, no toxicity, unhealthy cells. 13:57 We were able to confirm the synergy of action with gemcitabine, the chemotherapy. 14:03 And we noticed that the little mice 14:08 did not get any metastasis. 14:12 When a variant cancer is a cancer 14:15 that metastases very well a lot the rate of metastasis 14:20 with those new the mice with a very with no immune system 14:25 I mean is supposed to be in 80 something then. 14:29 Yeah. None of them I admit. 14:32 So we we looked also at 14:35 we look at pancreatic cancer. 14:37 We look at the synergy with carboplatin also. 14:41 I mean everything was we really quite 14:44 an impressive body of of science. 14:48 And again we spent created cancer. 14:51 The mice did not get metastasis at this point. 14:55 Our team at Kansas University Medical Center 14:59 started to speak of something that my father did not mention. 15:05 Nobody was pig at his time. 15:07 Nobody was speaking of cancer stem cells. 15:10 But now there is this emerging body 15:15 of science about cancer stem cells, 15:18 association of cancer, tumor 15:22 are able to resist chemotherapy, radiotherapy. 15:26 So conventional doctors do not speak about them because 15:30 nothing to offer with their conventional arsenal of treatment 15:35 that will destroy them. 15:36 So they just avoid the subject 15:39 and they are sought now 15:42 to be responsible for cancer metastasis. 15:45 So at the foundation, we decided to focus now 15:50 a new new research resources and cancer stem cells. 15:55 And over the years we have accumulated now 15:59 a beautiful study in vivo on creating cancer stem cells. 16:04 We have research also on a variant concept, step cells, both on Pereira and on. 16:12 And we just 16:13 wrapped up and it has been submitted for publications 16:18 for publication study on breast cancer stem cells. 16:22 And it is really, really important to me because breast cancer 16:27 is almost the number one killer for women, 16:31 definitely the most common cancer kind of cancer. 16:34 And there are one out of five women 16:38 was being diagnosed with breast cancer, 16:41 will eventually relapse if nothing is done. 16:46 Understood. 16:47 If she doesn't have proper port. 16:50 So then to develop something 16:53 that can significantly help and can be taken from day 16:58 one of the diagnosis without any toxicity, 17:02 without any side effects, I think that, you know, significant contribution. 17:08 And I am I'm very, very pleased with with the result. 17:12 Everything that we are doing at the Foundation gets published 17:16 and all the publications are available on the website of the foundation
Ovarian, Pancreatic, and Cancer Stem Cell Research 17:22 so people can 17:23 download them, read them, share them with their doctor and say, 17:28 well, you know, with based on the science, what would be the reason 17:32 not to take that supplement? 17:35 Because a lot of doctors and, you know, they just don't want 17:39 they look at you as a statistic when you have cancer, they don't think so 17:43 much of you as an individual that wants to take all the chances to heal better. 17:48 They are looking a little bit at us as stats, and they don't 17:52 want you to mess with their stats on how the conventional treatment 17:57 or the clinical trials in the world 18:00 you into as a big favor of that doing it to you. 18:04 But actually they are paid to undertake clinical trials, and they don't 18:09 want you to mess with the result of their precious clinical trial. 18:13 So they tell you, don't take anything, don't, don't, don't do anything. 18:17 Besides as, as a conventional treatment and your conventional protocol, 18:21 but in fact, you are not putting all the chances on your side. 18:25 And integrative medicine has so much more 18:28 to offer you all to yourself to learn 18:32 about what is available out there, 18:36 you all to yourself to get, you know, 18:39 a professional up with open minded 18:43 and no conflict of interest with Big Pharma 18:46 to help you and support you in this very, very difficult to journey. 18:51 So my contribution is to to continue 18:54 to make those little plant extracts available 18:58 and create a body of science to explain 19:03 how and why they can contribute. 19:07 I believe this can, you know, eventually shift the conversation, 19:12 make some open minded health professionals willing curious to try them, 19:18 especially considering that once again, the toxicity 19:22 unhealthy cells that have been studied by different teams on different organs, 19:28 the histology of the mice is showing that there is no damage 19:34 to the sea, to the organs. So, 19:39 I say read the science 19:42 and then do what you think is best for you. 19:46 Yeah. 19:46 And I that's what I feel so admirable 19:49 by what you are doing, is that you're really leaning into because. 19:54 Because anytime you go to medical doctor oncologists, 19:57 you know, they say it has not been studied. 19:59 It has not. 19:59 So they they kind of throw out these blanket statements that in reality 20:04 is that they haven't looked at anything themselves. 20:07 They're just they're just assuming because it is not a pharmaceutical drug 20:13 or that it is a, not a chemo agent, 20:16 that all of a sudden just because it's natural, it hasn't been studied. 20:20 And so you are helping to shift that scenario where you are, 20:26 you know, your foundation, all the money that goes in, all the money 20:29 that's raised goes into doing real clinical studies 20:34 to prove not not just kind of assume, but really prove 20:39 that these substances have an impact and what kind of impact they have. 20:43 And the cancer stem cells, that's a big deal. 20:47 Of course, we know when you do chemo, 20:50 you know you are not killing any cancer stem cells. 20:53 The cancer stem cells are still there, and they are the ones 20:57 that are going to kick in when you're done with chemo 21:00 and and create whatever it's created before you know it. 21:04 A stem cell essentially is designed to regenerate 21:09 and repair the tissue that it's associated with. 21:13 You know, so, you know, if you have a liver stem 21:16 cells, it is to then repair and regenerate the liver, kidney 21:20 cell, a stem cell repair, regenerate the kidney. 21:24 And now you have the cancer stem cells 21:26 is there to repair and regenerate cancer tissue. 21:31 So what happens when you do then an assault then to that tissue 21:36 is that the repair mechanism gets upregulated. 21:40 So the cancer stem cells actually kicks in even more 21:44 because now it feels like there's a wound to that tissue. 21:48 And now we got to heal that wound. 21:49 And so more the stem cells cancer stem cells get activated. 21:54 So if we can then combine. Yeah. 21:56 Let's let's say you choose to do chemo, you have to shrink the tumor. 22:00 But then to combine tools, then at the same time 22:03 that then targets the cancer stem cells. 22:06 And then to have science behind that what you're doing research 22:10 behind that to prove showing that these substances 22:15 actually go after the cancer stem cells of the different types of tumors. 22:21 Obviously haven't had time to research every possible cancer. 22:25 But so far from my understanding, what you've seen 22:29 is that each one that you have studied, you've seen the impact of, of these, 22:35 these substances, these natural, unharmed beneficial substances 22:39 that from nature that they are then targeting the stem cell in addition 22:44 to what you were talking about, that they go after the the genetic 22:49 structure of cancer cells, you know, 22:52 that have these loops that they and that is not part of the normal cells. 22:56 So in addition 22:57 to targeting the regular cancer cells, it also goes after the cancer stem cells. 23:02 Yes. And also inflammation. 23:04 We have studied that and on prostate and the mechanism of action. 23:09 And it's really really important also this inflammatory 23:12 anti-inflammatory benefit because inflammation is a cause of 23:17 so many diseases down the road beyond cancer. 23:21 So if we can have also something that fights inflammation 23:25 and at the same time as a anti-cancer benefit 23:29 with no toxicity, I would say why not? 23:32 Why not? Exactly. 23:34 And I just want to kind of backtrack a little bit to story with your father, 23:38 just to understand what a threat that his research was. 23:41 It was not just that they went in and try to get rid of the, 23:46 you know, the research. 23:48 They also coming in there with guns and then locking him 23:53 in, not letting him leave. 23:55 And they were all kind of masked up and then spreading some,
Why Integrative Oncology Matters 23:59 some kind of toxic substance that later on 24:03 probably was the reason of his demise. 24:06 Not that thereafter. Yeah. Yeah. 24:09 It says the says the all the products that was available, they voisin him 24:14 and then they let him die basically 24:18 without giving ever is there in court. 24:21 And that's why we were able to take the case 24:23 to the European Court of Human Rights and win eventually. 24:27 And in the numerous case before the Court of, of Human Rights. 24:31 But that's, you know, just a ways showing how the violence 24:36 actually of governments sometimes against evil in Europe, 24:42 I would say against everything that is integrated. 24:45 They have not no interest in 24:49 understanding the disease and understanding, 24:54 respecting the science, respecting the patient. 24:57 It's just a it. 24:59 They act like a cartel really. 25:01 Collusion between big pharma and one insurance system. 25:07 And beyond that 25:10 there is 25:11 no room for anything, nothing else is allowed. 25:14 And I am so grateful for this country, 25:18 for America to have allowed this, me 25:22 and this research to continue to to flourish 25:27 and to all those additional publications to get published 25:32 and to allow me to go to consensus, present this research and now of my own 25:38 conferences, the Belgian Integrative Cancer Conference, where I can, 25:42 you know, invite other voices 25:46 in the universe of integrative doctors 25:51 to just create kind of of body of knowledge of science, 25:56 a place where you can exchange ideas and exchange information goals. 26:02 And from there, I think this is just could not 26:06 have ever been possible in France. 26:09 Yeah. And I mean, America is not perfect. 26:12 Yeah, there are a lot of issues here as well, 26:15 but it is and I, I'm from Sweden, I love Sweden, I would not be able to do 26:20 the kind of therapies that I do here in Sweden. 26:23 So and it is interesting 26:25 that Americans have that mindset that things are better in Europe. 26:29 And yes, there are different things that that is available in Europe. 26:34 But there's a lot of freedom here that that we have. 26:37 And even though there are challenges, it still allow us to 26:42 to do many things that we would not be able to do elsewhere. 26:46 So it is yeah, it is phenomenal what we can do. 26:50 And, and you know, your your Bill Johnson conference, you know, 26:53 for all the listeners out there it is a phenomenal conference, you know. 26:58 So you should definitely make sure you get on the email list. 27:02 So you you learn about this and and there are phenomenal speakers. 27:06 See if I have yeah. 27:08 Let me let me show you what what I, what what I was given last time here 27:14 the integrative medicine visionary award. 27:16 Yeah. That from the well-deserved. 27:19 Well so so so yeah it was it was a really honored really pleasure. 27:25 So but the point is that the amount of research 27:29 and the amount of it's not like this is when you buy, you know, the Anchor 27:34 Bell Pro, you know, which is kind of the main product is aligned. Yes. 27:40 Absolutely. Yes. 27:41 Yes. The professional line. Exactly. 27:43 It is not that. 27:44 It's just a kind of a somebody that just threw some ingredients together. 27:48 No no no. 27:50 So, so each of the ingredient goes back from the research of my father's 27:54 or with the power which is coming from South America 27:58 and which was used in traditional 28:01 use from the 19th century in Brazil. 28:04 And there is documentation about that. 28:06 But my father perfected is very specific extract 28:10 which is devoid of Jesus and rich 28:14 in flavor, and identified 28:20 as active alkaloid array badge. 28:24 I mean, there is identity botanical identities of this 28:29 very specific extraction process that is after that the quality control 28:34 to verify that it's a starter dies extract with the content of of flavor. 28:39 And this this extract I mean, I would like to say the proof is it's a pudding. 28:44 All the publication the research showing that you know 28:49 the activity and different kind of cancer, different stages of cancer. 28:54 I mean it's comes with this extract 28:58 of the river 29:01 coming from Africa. 29:03 It's also a very specific extract. 29:05 Overthere is known for research but rather pink and be toxic. 29:10 So my father removes the reserve and he has an extract 29:14 which is really concentrated in astonishing and also in again, just like 29:19 the extract has been shown to again and again to be very, very effective
Beljanski Products and Research Evidence 29:25 against different kind of cancer, different stages of cancer. 29:29 We have the mechanism of action 29:32 now, the multiple mechanism of action 29:36 on different different cancer cell lines. 29:39 And, and, you know, the power of 29:43 and in Bell you also have the golden ginkgo. 29:47 People know about a lot about the winning streak because memory circulation. 29:53 And so this is made with Walden leaves. 29:55 So they are visited at a different time. 29:59 They are golden because the sun has changed. 30:02 The chemistry of the leaves and the different chemistry of the leaves 30:08 is going to give you a different extract. 30:11 And this extract, my father adds his time. 30:14 His publications show that he was able to help with skin fibrosis 30:20 that can result from from radiotherapy. 30:24 And then we did additional research with this, with this extract. 30:29 And we were able to see that it was also 30:33 inhibited inhibiting angiogenesis. 30:36 Arginine is this enzyme that help 30:40 cancer cells to create new blood vessels, so they can eat 30:44 a lot of additional nutrients to grow, multiply and grow. 30:49 And they will need also those blood vessels to spread to other organs. 30:54 So we are just starving them and preventing them to, 30:58 to start to, to spread with this ginkgo extract. 31:01 So the idea with on bell was to put all in one the purpose of 31:08 the golden gingko 31:10 all in one in little tablets, easy to take. 31:14 You take that orally. 31:16 You don't need to go get, you know, an IV somewhere. 31:19 I can take that orally. 31:21 And it's kind of one stop shop because again, 31:24 it's not gender organ specific. 31:27 And there is an we have never seen 31:30 any case of toxicity associated with the product. 31:34 So that's why I'm, I mean, make it available 31:38 to as many as many health professionals as possible. 31:42 I would like to add that to the research that we have done 31:46 has been on, except for the RNA fragments, and I would like 31:50 to speak separately at the final. 31:52 But for the golden eagle, 31:55 this study has been done in vitro and in animals. 31:59 So I would not present that, you know, as a clinical trials. But 32:06 I think we 32:06 have now between my father and me, 50 years 32:10 of good experience only with with this approach. 32:15 Yeah. 32:15 And obviously the French prime minister, the individuals 32:19 that have taken this and had, you know, phenomenal results with them. 32:24 And you, you know, just like normal research where you 32:27 you start with cell lines and then animals, this has proven itself, 32:31 you know, to be able to be effective in those areas. 32:35 And then, you know, for people like myself, and this is a core product 32:39 that I use at my center for the patients I come in dealing with cancer here, 32:44 and I just want to kind of, again, kind of for people to preach 32:48 that, you know, it's not just something that was thrown together. 32:51 This is decades of research. 32:53 And your father, you know, leading French scientists, 32:56 you know, Posterior Institute, French government thought that this was, 33:01 you know, so dangerous that they wanted to, you know, 33:05 so usually if it's something that's useless and doesn't work, it's not. 33:10 Nobody cares. 33:10 But but they cared so much that they, you know, 33:14 they brought the government in, destroy the evidence 33:17 and then also resulted what the action 33:20 that they took resulted then in your, your father, you know, dying. 33:25 And then obviously that would then stop his legacy in their mind. 33:29 But then you took that on and then now you've advanced. 33:34 So you built on top of that research all the decades of research that he did 33:39 and added more decades and added bringing in Columbia University, 33:44 you know, the research they're proving, in addition to what he was seeing 33:48 now, also, the discussion of the cancer stem cells, the impact 33:52 that this product has on that as well, so that I just want people to 33:57 what is behind, you know, in in a 34:00 little in a little box like this, you know, the, the blood, sweat and tears 34:03 and the research that exists, you know, for this to be available to the public. 34:08 And I think that is it is amazing. 34:11 Thank you, thank you. Yeah. 34:13 And so as a product I would like to to speak about quickly 34:17 is made of RNA fragments. 34:19 And I would like to speak about that because yes, 34:23 this is 34:23 I would like to speak quickly about that because this is totally unique. 34:27 And those little RNA fragments that do not come from nature, 34:32 they were kind of created by my, my father out of bacteria. 34:38 And he may also the observations 34:43 that I mean, those are the DNA of the bone marrow could be pinned 34:48 with a little specific RNA. 34:52 And the that was an idea that he had to create out of nowhere, 34:56 those little RNA fragments. 34:59 And they are indeed specific of the DNA of the bone marrow. 35:03 They help the bone marrow 35:04 create a new generation of white blood cells and platelets. 35:08 And that's really, really important because those blood cells are fast 35:13 dividing. 35:14 Therefore, they are often collateral damage or chemotherapy and radiotherapy. 35:22 They are destroyed along cancer cells, but they are the core of our immune system. 35:27 And this is a natural nutritional approach 35:31 really, to feed the bone marrow 35:35 with what it needs to 35:39 survive properly, the conventional treatments. 35:43 And we were able to have a clinical trial at Cancer Treatment Centers of America
RNA Fragments and Bone Marrow Support 35:48 with people population who had very advanced 35:51 already several rounds of chemotherapy already. 35:55 Some even had cancer to the bone and the bone marrow, 35:59 and they were all at the verge of tremble, 36:02 which is a complete loss of platelets. 36:06 Technically, they did not have 36:09 to give them so the product as a 36:11 as a dietary supplements because forget about the cancer. 36:15 So did not have thrombocytopenia. 36:16 That's what was what was studied. 36:18 So what we are able to see is that not only those 36:22 very immune suppressed patients. 36:24 And here we are speaking of patients and hospital setting. 36:30 Nobody had side effects, which was actually an escalation 36:34 does from 20 to 80mg. 36:36 Nobody had side effects. 36:38 And they were all did very well known, 36:42 had to stop the treatment of their chemotherapy 36:46 so that continue to add chemotherapy during during the clinical trials. 36:50 The idea to see was to see if they were going to fall into. 36:55 None of them did fall into the trap, 36:59 and there were all their bone marrow was doing better 37:04 at the end of the clinical trial than at the beginning. 37:08 So that's a very big again, because there is no toxicity, 37:13 no side effects of the little RNA fragments are not priming anything else 37:18 than the healthy bone marrow that we I want to speak about that 37:23 because I think it is also an amazing, amazing discovery 37:27 and very, very, very unique. 37:29 It's not, you know, growth factor because a lot of very often, 37:33 I mean, in order to fight the risk of 37:36 giving you at the hospital some growth factor, 37:39 but you cannot take Horse Factor for a long time. 37:42 Here you have some things that you can take for a long time 37:46 without the with without side effects. 37:50 Yeah. 37:51 And so yeah, this this is something that I use any, 37:55 any cancer patients has gone through chemo you know 37:59 is what I always, always bring in and 38:02 and because that's the thing if you are doing chemo 38:05 the worst or the oncologist, the last thing they want 38:08 is to have to space out the, the chemo treatment or stop chemo treatment 38:14 just because the patient physically can't handle it. 38:17 And because the hemoglobin, the platelets, the white blood cells, 38:21 all of that drops. 38:23 And now you get into a danger because your, your 38:27 you know, it's a slight threatening at that point. 38:30 So what the goal if you are choosing then to do chemo to make sure 38:35 that you're able to receive the appropriate amount of treatment, 38:39 to have the impact on the cancer that you're wanting to have, 38:42 and to be able to bring in some a tool that enables you 38:47 to complete your treatment becomes really, really powerful. 38:51 And and I know from a, you know, 38:53 from experience that, you know, patients that have gone through chemo 38:57 without the protection, you know, these kind of mutable protection. 39:01 Yeah it does. 39:02 Chemo leaves a scar on the bone marrow. 39:05 It just does. 39:05 And so anything you can do to protect your bone marrow 39:10 and support the production of your red blood cells 39:13 and white blood cells becomes really, really important. 39:17 So, you know, for anyone 39:19 you know, you know of anyone that is going through that. 39:22 And this is a it's a powerful adjunct to that to enable the individual 39:27 to stay stronger after chemo so that they're not vulnerable.
Closing Reflections on the Foundation's Work 39:32 And yeah, so so thank you so much for that. 39:36 Thank you Sylvie. 39:37 Well thank you. 39:38 Thank you very much. 39:39 Yeah. 39:40 Thank you. 39:40 Well, and then I mean, there are other products 39:43 that are available, you know, the the woman Bell you have prostate 39:47 Bell, you have other products that are available that you can look at. 39:51 I urge everyone, though, to go to the foundation's research or foundation 39:56 site and look at the research that is there so you can understand, 40:01 you know, the quality of what these products, what they what they do. 40:06 So I really applaud you, Sylvie, for all the effort that you put forth 40:10 because you don't need to. 40:12 You didn't need to. 40:13 Yeah. 40:14 You could just sell the product and be good with that. 40:16 But you really want to kind of put a mark in, you know, 40:20 showing that these natural agents, you know, the impact 40:23 they have and continue the legacy and the research of what your father did. 40:27 So, so it's every public new 40:30 publication is kind of like the gifts that keeps giving. 40:33 And it gives me 40:34 nothing, makes give me more joy and maybe, maybe more proud than those 40:39 after publication 40:41 showing the array of possibilities 40:45 that come with those little plot extracts and the RNA fragments. 40:50 Great. Oh, thank you. 40:51 Thank you so much, Sylvie. Thank you, thank you.
Comments